GO:0140616 iodotyrosine deiodinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140616 iodotyrosine deiodinase activity catalyzes the NADPH-dependent reductive deiodination of 3,5-diiodo-L-tyrosine to L-tyrosine and iodide, and can also act on 3-bromo-L-tyrosine and 3-chloro-L-tyrosine.
• The enzyme is a nitroreductase-fold flavoprotein that uses FMN and NADPH, with redox control of its catalytic cycle.
• The activity is central to thyroid hormone metabolism because it salvages iodide from monoiodotyrosine and diiodotyrosine, recycling iodide for new hormone synthesis.
• The distribution and mechanism of iodotyrosine deiodinase have defied expectations, with homologs found in diverse organisms and unusual substrate specificity.
• Halogenated compounds can inhibit iodotyrosine deiodinase, making it a target for toxicological and pharmacological studies.
• Selenium status and nutritional factors influence thyroid hormone metabolism and thyroid disease, indirectly affecting deiodinase-related pathways.
Description
Iodotyrosine deiodinase activity (GO:0140616) is a molecular function that enables the reductive removal of iodine from iodinated tyrosine residues, primarily converting 3,5-diiodo-L-tyrosine to L-tyrosine and iodide. This activity is essential for iodide salvage in the thyroid gland, where it helps recycle iodide from monoiodotyrosine and diiodotyrosine generated during thyroid hormone synthesis. The enzyme uses NADPH as an electron donor and flavin mononucleotide (FMN) as a cofactor, and its catalytic mechanism is subject to redox control. The reaction is unusual because it has only been demonstrated in the direction of 3-deiodination, and it can also act on brominated and chlorinated tyrosine analogs. Researchers study GO:0140616 because of its role in thyroid hormone homeostasis and its potential impact on thyroid disease, nutritional status, and toxicology. The enzyme's ability to deiodinate halogenated tyrosines links it to broader questions about halogen metabolism and detoxification. Moreover, the discovery of iodotyrosine deiodinase homologs in bacteria and other organisms has expanded its relevance beyond vertebrate endocrinology. Understanding this activity at the molecular level can inform studies of thyroid dysfunction, iodine recycling, and the effects of environmental halogenated compounds. This article provides a research-grade overview of GO:0140616, covering its definition, mechanism, key genes, disease associations, and experimental approaches. It is designed for scientists, clinicians, and students who need a concise yet authoritative resource on iodotyrosine deiodinase activity.
iodotyrosine deiodinase activity At A Glance
| GO ID | GO:0140616 |
|---|---|
| GO term | iodotyrosine deiodinase activity |
| Ontology | molecular_function |
| Synonym | iodide peroxidase-tyrosine iodinase activity; iodotyrosine deiodase activity; monoiodotyrosine deiodinase activity; tyrosine iodinase activity |
| Major function | Reductive deiodination of 3,5-diiodo-L-tyrosine to L-tyrosine and iodide, using NADPH as electron donor |
| Cofactor | Flavin mononucleotide (FMN) |
| Substrates | 3,5-diiodo-L-tyrosine; 3-bromo-L-tyrosine; 3-chloro-L-tyrosine |
| Reaction direction | Demonstrated only in the 3-deiodination direction |
| Cellular role | Iodide salvage in thyroid hormone synthesis |
What Is GO:0140616?
GO:0140616 iodotyrosine deiodinase activity is defined by the Gene Ontology as catalysis of the reaction: 2 iodide + L-tyrosine + 2 NADP+ = 3,5-diiodo-L-tyrosine + H+ + 2 NADPH. The activity has only been demonstrated in the direction of 3-deiodination, meaning it removes iodine from the 3-position of iodinated tyrosines. It can also use 3-bromo-L-tyrosine and 3-chloro-L-tyrosine as substrates. Synonyms include iodide peroxidase-tyrosine iodinase activity, iodotyrosine deiodase activity, monoiodotyrosine deiodinase activity, and tyrosine iodinase activity.
Why Is iodotyrosine deiodinase activity Important in Cell Biology?
Iodotyrosine deiodinase activity is critical for thyroid hormone economy because it recycles iodide from iodinated tyrosine byproducts, allowing the thyroid gland to conserve this essential trace element. Defects in iodide salvage can lead to iodine deficiency and impaired thyroid hormone production, which is relevant to thyroid disease and nutritional disorders. The enzyme also interacts with halogenated environmental compounds, making it a potential target for toxicological studies. Furthermore, the redox regulation of iodotyrosine deiodinase highlights its sensitivity to cellular oxidative state, linking it to broader redox biology.
• Enables iodide recycling in the thyroid, reducing the need for dietary iodine.
• Supports thyroid hormone synthesis by salvaging iodide from monoiodotyrosine and diiodotyrosine.
• Its inhibition by halogenated compounds may disrupt thyroid function.
• Redox control of the enzyme connects it to cellular oxidative stress responses.
• Selenium and other nutritional factors that affect thyroid metabolism may influence deiodinase pathways.
• Homologs in diverse organisms suggest broader roles in halogen metabolism.
• Provides a model for studying flavin-dependent dehalogenation reactions.
• Relevant to autoimmune thyroid disease and postpartum thyroiditis through thyroid hormone dysregulation.
• Potential target for drugs modulating thyroid hormone levels.
• Important for understanding iodine deficiency disorders and thyroid gland physiology.
Molecular Mechanism of iodotyrosine deiodinase activity
Substrate binding and specificity
In simple terms: The enzyme grabs onto iodinated tyrosine molecules and holds them in place for deiodination.
Iodotyrosine deiodinase binds 3,5-diiodo-L-tyrosine and related halogenated tyrosines with specificity that accommodates iodine, bromine, or chlorine at the 3-position. The enzyme's active site is tailored to position the substrate for reductive dehalogenation, and structural studies have revealed a nitroreductase-like fold. Substrate analogs such as 3-bromo-L-tyrosine and 3-chloro-L-tyrosine can also be used, indicating relaxed halogen specificity.
Flavin cofactor and electron transfer
In simple terms: A vitamin B2-derived molecule (FMN) shuttles electrons to break the carbon-halogen bond.
The enzyme utilizes flavin mononucleotide (FMN) as a prosthetic group, which is reduced by NADPH. The reduced FMN then transfers electrons to the halogenated substrate, leading to dehalogenation and release of halide ion. This mechanism is characteristic of flavin-dependent reductive dehalogenases and is subject to redox regulation.
Catalytic cycle and redox control
In simple terms: The enzyme cycles between oxidized and reduced states, and its activity is tuned by the cell's redox environment.
The catalytic cycle involves NADPH binding, flavin reduction, substrate deiodination, and product release. Redox control of iodotyrosine deiodinase has been demonstrated, with the enzyme's activity modulated by oxidative conditions. This regulation may protect the enzyme from oxidative damage and link its function to cellular redox status.
Reaction direction and products
In simple terms: The enzyme removes iodine from the 3-position, producing iodide and tyrosine.
The reaction catalyzed by GO:0140616 is the reductive deiodination of 3,5-diiodo-L-tyrosine to L-tyrosine and iodide, with NADPH as the electron donor. The activity has only been demonstrated in the 3-deiodination direction, and the reverse reaction has not been observed. The released iodide can be recycled for thyroid hormone synthesis.
Inhibition by halogenated compounds
In simple terms: Other halogenated chemicals can block the enzyme, potentially disrupting thyroid function.
Structure-activity relationship studies of 44 halogenated compounds have shown that various environmental halogens can inhibit iodotyrosine deiodinase. This inhibition may interfere with iodide salvage and thyroid hormone production, raising concerns about endocrine-disrupting chemicals. The inhibitory potency depends on the halogen type and substitution pattern.
Key Genes Involved in GO:0140616 iodotyrosine deiodinase activity
The primary gene encoding iodotyrosine deiodinase activity is IYD (iodotyrosine deiodinase), but other genes involved in thyroid hormone metabolism and redox regulation also influence this activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IYD | Encodes iodotyrosine deiodinase, the enzyme catalyzing GO:0140616 | Core gene for iodide salvage; mutations linked to thyroid dysfunction |
| DIO1 | Type I iodothyronine deiodinase, activates thyroid hormone | Related deiodinase family member; affects thyroid hormone levels |
| DIO2 | Type II iodothyronine deiodinase, local T3 production | Influences thyroid hormone action in tissues; regulated by leptin and CELF1 |
| DIO3 | Type III iodothyronine deiodinase, inactivates thyroid hormone | Modulates thyroid hormone availability during development |
| TPO | Thyroid peroxidase, iodinates tyrosine residues in thyroglobulin | Provides iodinated substrates for IYD; key for hormone synthesis |
| TG | Thyroglobulin, precursor protein for thyroid hormones | Source of monoiodotyrosine and diiodotyrosine for IYD |
| SLC5A5 | Sodium-iodide symporter, mediates iodide uptake | Supplies iodide for thyroid hormone synthesis and recycling |
| SLC26A4 | Pendrin, mediates iodide efflux | Facilitates iodide transport in thyroid cells |
| TSHR | Thyroid-stimulating hormone receptor | Regulates thyroid gland function and hormone synthesis |
| PAX8 | Thyroid transcription factor | Controls expression of thyroid-specific genes including IYD |
| NKX2-1 | Thyroid transcription factor 1 | Regulates thyroid development and gene expression |
| FOXE1 | Thyroid transcription factor 2 | Involved in thyroid morphogenesis and gene regulation |
| SECISBP2 | Selenocysteine insertion sequence-binding protein 2 | Affects selenoprotein synthesis, including deiodinases |
| GPX1 | Glutathione peroxidase 1 | Redox regulation may impact IYD activity |
| SOD1 | Superoxide dismutase 1 | Cellular redox balance influences IYD function |
| NQO1 | NAD(P)H quinone dehydrogenase 1 | Provides NADPH for reductive reactions; supports IYD cofactor regeneration |
| CELF1 | RNA-binding protein stabilizing Dio2 mRNA | Indirectly affects thyroid hormone activation |
| LEP | Leptin, enhances intracellular thyroid hormone activation | Regulates energy balance via thyroid hormone pathways |
How Is iodotyrosine deiodinase activity Regulated?
Iodotyrosine deiodinase activity is regulated at multiple levels. Its catalytic cycle is subject to redox control, with the enzyme's activity modulated by the cellular oxidative environment. Expression of the IYD gene is controlled by thyroid-specific transcription factors such as PAX8 and NKX2-1, which coordinate thyroid hormone synthesis. Additionally, nutritional factors including selenium status can influence deiodinase family enzymes and thyroid hormone metabolism. Leptin has been shown to enhance intracellular thyroid hormone activation in skeletal muscle, indirectly affecting deiodinase pathways. The RNA-binding protein CELF1 stabilizes Dio2 mRNA, linking post-transcriptional regulation to thyroid hormone action.
iodotyrosine deiodinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IYD | Thyroid dyshormonogenesis, iodine deficiency | IYD knockout mouse or thyroid cell line |
| TPO | Congenital hypothyroidism | TPO mutant zebrafish or patient-derived iPSCs |
| TG | Thyroid dyshormonogenesis | TG knockout mouse |
| SLC5A5 | Iodide transport defect | SLC5A5 knockout cell model |
| DIO2 | Thyroid hormone resistance, metabolic disorders | DIO2 overexpression or knockout in skeletal muscle cells |
Thyroid dyshormonogenesis and iodine deficiency
Impaired iodotyrosine deiodinase activity can lead to inefficient iodide recycling, contributing to iodine deficiency and thyroid dyshormonogenesis. This may result in goiter and hypothyroidism, particularly in populations with low iodine intake. Nutritional factors such as selenium deficiency can exacerbate thyroid dysfunction by affecting deiodinase enzymes.
Autoimmune thyroid disease and postpartum thyroiditis
Autoimmune thyroid diseases, including Hashimoto's thyroiditis and Graves' disease, involve altered thyroid hormone metabolism that may interact with deiodinase pathways. Postpartum thyroiditis is a common autoimmune thyroid disorder that can affect thyroid hormone levels and potentially influence iodide salvage mechanisms. The role of iodotyrosine deiodinase in these conditions is an area of ongoing research.
Toxicological effects of halogenated compounds
Environmental halogenated compounds can inhibit iodotyrosine deiodinase, potentially disrupting thyroid hormone homeostasis. This inhibition may contribute to endocrine disruption and thyroid disease in exposed populations. Understanding these interactions is important for risk assessment of halogenated pollutants.
From iodotyrosine deiodinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does IYD loss impair iodide recycling? | IYD knockout thyroid cell line or mouse model |
| How do point mutations in IYD affect enzyme activity? | Point-mutation knock-in of IYD in HEK293 cells |
| Can tagged IYD be used to track subcellular localization? | Knock-in of fluorescent or epitope tag at IYD locus |
| Does IYD overexpression enhance iodide salvage? | Overexpression of IYD in thyroid cells |
| Which genes interact with IYD in thyroid hormone synthesis? | CRISPR library screening in thyroid cells |
| How does redox state regulate IYD activity? | Point mutations in redox-sensitive residues of IYD |
How to Study the iodotyrosine deiodinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| HPLC-based deiodinase assay | Conversion of diiodotyrosine to tyrosine and iodide | Enzyme kinetics and inhibitor testing |
| NADPH oxidation assay | NADPH consumption during deiodination | High-throughput screening |
| X-ray crystallography | Three-dimensional structure of IYD | Mechanistic studies |
| RNA-seq | Transcript levels of IYD and related genes | Expression profiling in thyroid disease |
| CRISPR knockout | Loss-of-function phenotypes | Functional validation of IYD in iodide recycling |
| CRISPR knock-in | Tagged or mutant IYD expression | Localization and structure-function studies |
| Proteomics | Protein interactions and post-translational modifications | Identifying IYD regulatory networks |
| Metabolomics | Iodotyrosine and iodide levels | Measuring pathway flux in thyroid cells |
Enzymatic assays for deiodinase activity
Iodotyrosine deiodinase activity can be measured using spectrophotometric or HPLC-based assays that monitor the conversion of 3,5-diiodo-L-tyrosine to L-tyrosine and iodide. These assays typically include NADPH and FMN to support the reaction and can be adapted for high-throughput screening of inhibitors.
Structural biology and biophysics
X-ray crystallography and cryo-EM can reveal the atomic structure of iodotyrosine deiodinase and its substrate complexes, providing insights into catalytic mechanism and halogen specificity. Biophysical methods such as isothermal titration calorimetry can quantify substrate binding affinities.
Gene expression and transcriptomics
RNA-seq and qPCR can measure IYD mRNA levels in thyroid tissues or cell models under different conditions. Transcriptomic profiling can identify co-regulated genes in thyroid hormone synthesis pathways.
CRISPR-based functional genomics
CRISPR knockout and knock-in models enable precise manipulation of IYD and related genes to study their roles in iodide salvage and thyroid function. Library screening can identify modifiers of deiodinase activity.
How CRISPR Can Be Used to Study GO:0140616 iodotyrosine deiodinase activity
Knockout
CRISPR knockout of IYD can abolish iodotyrosine deiodinase activity, leading to impaired iodide salvage and altered thyroid hormone synthesis in cell models. Knockout mice may exhibit thyroid dysfunction under iodine-deficient conditions.
Point Mutation
Introducing point mutations in the IYD active site or cofactor-binding residues can dissect the catalytic mechanism and redox regulation of the enzyme. Such models help identify residues critical for substrate binding and FMN interaction.
Knock-in
Knock-in of epitope-tagged or fluorescently tagged IYD allows real-time tracking of enzyme localization and dynamics in thyroid cells. This approach can also be used to express disease-associated IYD variants.
Overexpression
Overexpression of IYD in thyroid or non-thyroid cells can enhance iodide salvage and increase resistance to halogenated compound toxicity. It also provides a system for biochemical purification and structural studies.
How EDITGENE Supports iodotyrosine deiodinase activity Research
Researchers studying iodotyrosine deiodinase activity-related genes often need to determine whether a candidate gene is causally involved in iodide salvage, thyroid hormone synthesis, or halogen metabolism. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for iodotyrosine deiodinase activity research.
Frequently Asked Questions About iodotyrosine deiodinase activity
What is iodotyrosine deiodinase activity?
Iodotyrosine deiodinase activity (GO:0140616) is a molecular function that catalyzes the reductive deiodination of 3,5-diiodo-L-tyrosine to L-tyrosine and iodide, using NADPH as an electron donor.
What genes are involved in iodotyrosine deiodinase activity?
The primary gene is IYD, which encodes the enzyme. Other related genes include DIO1, DIO2, DIO3, TPO, TG, and SLC5A5, which are involved in thyroid hormone metabolism.
What is the function of GO:0140616?
GO:0140616 enables iodide salvage by removing iodine from iodinated tyrosine residues, recycling iodide for thyroid hormone synthesis.
Which cofactors are required for iodotyrosine deiodinase activity?
The enzyme requires flavin mononucleotide (FMN) as a prosthetic group and NADPH as an electron donor.
Can iodotyrosine deiodinase act on brominated or chlorinated tyrosines?
Yes, 3-bromo-L-tyrosine and 3-chloro-L-tyrosine can also be used as substrates, indicating relaxed halogen specificity.
How is iodotyrosine deiodinase activity regulated?
It is regulated by redox conditions and potentially by thyroid-specific transcription factors; nutritional factors such as selenium may also influence related pathways.
What diseases are associated with iodotyrosine deiodinase dysfunction?
Impaired activity may contribute to thyroid dyshormonogenesis, iodine deficiency, and altered thyroid hormone metabolism in autoimmune thyroid disease.
How can I study iodotyrosine deiodinase activity in the lab?
Common methods include enzymatic assays with HPLC or NADPH oxidation, CRISPR knockout/knock-in models, and structural biology approaches.
What is the reaction catalyzed by GO:0140616?
The reaction is: 2 iodide + L-tyrosine + 2 NADP+ = 3,5-diiodo-L-tyrosine + H+ + 2 NADPH, with activity demonstrated only in the 3-deiodination direction.
Are there inhibitors of iodotyrosine deiodinase?
Yes, various halogenated compounds can inhibit the enzyme, with structure-activity relationships studied for 44 halogenated compounds.
Conclusion
Iodotyrosine deiodinase activity (GO:0140616) is a specialized molecular function essential for iodide salvage and thyroid hormone metabolism. Its flavin-dependent catalytic mechanism, redox regulation, and inhibition by environmental halogens make it a compelling target for endocrine and toxicological research. Understanding this activity can illuminate thyroid disease mechanisms and guide the development of new diagnostic and therapeutic strategies. EDITGENE's CRISPR services provide powerful tools to dissect the genetic and molecular basis of iodotyrosine deiodinase activity, from knockout and point mutation models to library screening and bioinformatics. By leveraging these technologies, researchers can accelerate discoveries in thyroid biology and beyond.
References
- 1. Lu J et al.. 2009. Selenoproteins.. J Biol Chem 284(2):723-7 PMID: 18757362
- 2. Rayman MP. 2019. Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease.. Proc Nutr Soc 78(1):34-44 PMID: 30208979
- 3. Shimizu R et al.. 2013. Structure-activity relationships of 44 halogenated compounds for iodotyrosine deiodinase-inhibitory activity.. Toxicology 314(1):22-9 PMID: 24012475
- 4. Sun Z et al.. 2017. The distribution and mechanism of iodotyrosine deiodinase defied expectations.. Arch Biochem Biophys 632:77-87 PMID: 28774660
- 5. Lazarus JH et al.. 2002. Postpartum thyroiditis.. Autoimmunity 35(3):169-73 PMID: 12389641
- 6. Miro C et al.. 2025. Leptin enhances the intracellular thyroid hormone activation in skeletal muscle to boost energy balance.. Cell Metab 37(4):936-953.e7 PMID: 39986272
- 7. Zeng T et al.. 2025. Adipocyte RNA-binding protein CELF1 promotes beiging of white fat through stabilizing Dio2 mRNA.. Nat Commun 16(1):7414 PMID: 40789858
- 8. Hu J et al.. 2019. Redox control of iodotyrosine deiodinase.. Protein Sci 28(1):68-78 PMID: 30052294
